Ischaemic tolerance: a window to endogenous neuroprotection?
Schaller
Bernhard
B
Max Planck Institute for Neurological Research, Cologne, Germany. bernhard.schaller@pet.mpin-koeln.mpg.de
Graf
Rudolf
R
Jacobs
Andreas H
AH
D000222:Adaptation, Physiological / Q000502:physiology; D000818:Animals; D017209:Apoptosis / Q000502:physiology; D002545:Brain Ischemia / Q000188:drug therapy / Q000503:physiopathology*; D002560:Cerebrovascular Circulation / Q000502:physiology*; D004195:Disease Models, Animal; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D015870:Gene Expression; D006360:Heat-Shock Proteins / Q000096:biosynthesis / Q000502:physiology; D006801:Humans; D019194:Ischemic Preconditioning / Q000379:methods; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use; D012039:Regional Blood Flow / Q000502:physiology
D005343:Fibrinolytic Agents; D006360:Heat-Shock Proteins; D018696:Neuroprotective Agents